
ヘルスとヘルスケア
健康的な生活を促進し、すべての人が手頃な価格で質の高い医療を受けられるようにするとともに、医療業界を変革する。
Earli locates cancer early, when it is much more curable. Rather than rely on biomarkers that cancer may – or often may not – naturally provide, Earli's technology “forces” cancer cells to make a precise synthetic, non-human biomarker to localize the cancer. This new approach is called synthetic biopsy. In the future, the same platform might also be usable to trigger localized therapeutic responses inside the cancer.